Venezuelan Equine Encephalomyelitis

1

Review clinical trials related to Venezuelan Equine Encephalomyelitis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults

The purpose of this study is to evaluate the safety and immunogenicity of VEE vaccine, C-84, TSI-GSD 205, Lot 7, Run 1, and collect data on the incidence of occupational VEE infection in vaccinated personnel.

Participants needed: 500
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: U.S. Army Medical Research and Development CommandUpdated: Feb 16, 2021Locations: 1
Eligibility criteria

Be 18 to 65 years old at time of consent [+12]

Have completed previous VEE C-84 vaccine study as a non-responder. [+16]